Connecting Global Pharmaceutical Innovation with the Iraqi Healthcare Market
Since 1997, Al Sumo Scientific Bureau has connected international pharmaceutical excellence with patients, healthcare professionals, hospitals, pharmacies, and institutions across Iraq.
A Leading Force in Iraqi Pharmaceutical Distribution
Scale, infrastructure, and scientific capability — measured.
Source: Al Sumo Scientific Bureau Company Profile 2026 (data as of 2024). Market and financial figures are editable and should be reviewed periodically against the latest validated internal and IQVIA / Ministry of Health sources.
A Leading Player in Iraqi Pharmaceutical Distribution
Al Sumo Scientific Bureau is an integrated pharmaceutical distribution, regulatory, commercialization, and scientific-promotion group headquartered in Baghdad.
We provide international healthcare companies with a complete platform for entering, registering, launching, distributing, promoting, and expanding their products across Iraq — supported by regional group companies in Amman, London, and Erbil.
Al Sumo national cycle meeting
One of the Region's Most Promising Healthcare Markets
Iraq combines scale, growth, and unmet demand — a strategic opportunity for international manufacturers with the right local partner.
$4.6B market size
Total Iraqi pharmaceutical market value (2024), ranked among the top 3 fastest-growing markets in MENA.
12.5% annual growth
Sustained CAGR driven by chronic-disease management, hospital investment, and expanding healthcare access.
$200M+ insulin potential
Diabetes, cardiovascular, and oncology demand define one of the region's largest specialty opportunities.
Infrastructure investment
Major government investment in healthcare infrastructure and new hospitals across the country.
3,000+ pharmacists yearly
A rapidly growing professional workforce expanding the national pharmacy and hospital network.
Strategic regional position
A gateway for regional pharmaceutical trade at the heart of the Middle East.
Source: IQVIA / Ministry of Health reports 2024. Market figures should be reviewed and updated periodically based on the latest validated IQVIA, Ministry of Health, and other approved sources.
From Registration to Nationwide Commercialization
One accountable partner across the complete market-entry lifecycle.
Portfolio & Market Assessment
Opportunity mapping, competitor & price benchmarking, forecasting.
Regulatory Feasibility
Dossier gap analysis and registration strategy for Iraq MOH.
Manufacturing-Site Registration
Site file preparation, legalization, and MOH follow-up.
Product Registration
CTD review, sample & lab coordination, submission management.
Pricing & Import Approval
Pricing applications, import permits, and customs coordination.
Launch Strategy
Segmentation, targeting, launch sequencing, and KOL planning.
Scientific Promotion
150+ medical reps detailing to physicians and pharmacies.
Nationwide Distribution
48-hour delivery across all 18 governorates, cold chain included.
Pharmacovigilance & Lifecycle
Safety coordination, renewals, variations, and compliance.
Growth & Portfolio Expansion
New SKUs, tender opportunities, and market-share optimization.
Everything an International Partner Needs — Under One Roof
Regulatory Affairs
End-to-end coordination of manufacturing-site registration, product registration, dossier preparation, pricing, renewals, import permits, and lifecycle management.
Learn moreNationwide Distribution
Integrated delivery coverage across all 18 Iraqi governorates, serving pharmacies, drugstores, hospitals, clinics, institutions, and governmental entities.
Learn moreScientific Promotion
A field force of 150+ medical representatives supported by supervisors, scientific teams, KOL engagement, and evidence-based communication.
Learn moreWarehousing & Cold Chain
GDP-aligned pharmaceutical storage, temperature-controlled facilities, cold-chain logistics, monitoring systems, and refrigerated transportation.
Learn moreMarket Access & Commercialization
Market analysis, pricing strategy, launch planning, segmentation, forecasting, sales execution, tender participation, and brand development.
Learn moreBusiness Development & Licensing
Exclusive distribution, in-licensing, private label, contract manufacturing, MAH-support models, co-marketing, and strategic joint ventures.
Learn moreSpecialty Depth Across the Portfolio
From chronic care to advanced hospital specialties.
Oncology
Targeted therapies and biosimilars for cancer care.
Read moreEndocrinology
Hormonal therapies and complex metabolic disorder treatments.
Read moreDiabetes & Metabolic Care
Comprehensive diabetes management across Iraq.
Read moreCardiovascular
Hypertension, lipid management and cardiac care.
Read moreGastroenterology
Digestive health solutions for hospital and retail channels.
Read moreGynecology & Women's Health
Dedicated portfolios for women's health at every stage.
Read moreFertility & Hormonal Therapies
Specialized fertility and hormonal treatment support.
Read moreInfectious Diseases
Antibiotics, antifungals and hospital-grade injectables.
Read moreRespiratory & Allergy
Anti-allergics, antihistamines and expanding asthma care.
Read moreNeurology & Psychiatry
CNS therapies with specialist scientific engagement.
Read moreCritical Care & Anesthesia
Hospital-critical therapies, anesthetics and injectables.
Read moreConsumer Healthcare & Supplements
Premium multivitamin and wellness portfolios (MVS).
Read moreBuilt for Reliable Pharmaceutical Supply
A GDP-aligned logistics platform engineered for product integrity — from the port of entry to the furthest pharmacy shelf.
- Baghdad logistics hub — ~7,000 m³, four floors
- 2,280 pallet positions per floor
- Basra & Erbil regional warehouses
- Cold rooms & refrigerated fleet
- 24/7 IoT temperature monitoring
- Real-time inventory & batch traceability
- 48-hour nationwide delivery capability
- Advanced ERP — SAP / Oracle integration ready
21.5°C · monitored 24/7
150+ medical representatives · 20+ supervisors
Scientific Promotion at National Scale
- Scientific detailing to physicians and healthcare providers in all 18 governorates
- KOL engagement, advisory boards, and medical conferences
- Continuing medical education and product-launch programs
- Sales-force automation with real-time field reporting
“We ensure that our partners are not merely represented on pharmacy shelves, but actively positioned within the Iraqi healthcare community.”
Trusted Partnerships Across Global Healthcare Markets
Long-term relationships with manufacturers from Europe, the United Kingdom, India, and the Middle East.
A Regional Platform with Global Reach
Four companies, one integrated partner — spanning Iraq, Jordan, the United Kingdom, and the Kurdistan Region.
Al Sumo Scientific Bureau
Headquarters and primary pharmaceutical distribution platform — 150+ medical representatives nationwide.
HeadquartersDr. Health for Import & Export
Regional regulatory, documentation, and business-development hub. Established 2015 — serving Jordan, KSA, UAE, and Lebanon.
Regional HubSumo London
International partnership gateway founded 2020 — European coordination, regulatory and logistics support.
International BridgeSharez Company
Registration and distribution across Erbil & Sulaymaniyah — registered with the Kurdistan Medical Control Agency.
Sister Company
UAE Expansion
Strategic expansion into the United Arab Emirates market — extending the group's regional platform to the Gulf.
Baghdad Headquarters
- Al-Mansour, Hay Al-Mutanabi, Baghdad, Iraq
- General: info@alsumo.com.iq · Compliance: compliance@alsumo.com.iq
- +964 771 779 1999 · +962 79 999 1068
- Sun – Thu · 8:30 – 17:00 (Baghdad)
- WhatsApp business line